Dr. Rosenbloom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
908 Jefferson St
Seattle, WA 98104Phone+1 206-616-8948
Summary
- Dr. Rosenbloom is a board-certified neurologist at the UW Medicine Memory and Brain Wellness Center where he directs the clinical trials running at the UW Alzheimer’s Disease Research Center (ADRC) in Seattle, WA. He previously served for 13 years as director of the HealthPartners Center for Memory and Aging in St. Paul, MN where he led clinical research in cognitive screening for dementia, intranasal therapeutics, and non-invasive neurostimulation for neurodegenerative diseases.
Education & Training
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Certifications & Licensure
CA State Medical License 2008 - Present
WA State Medical License 2022 - 2025
MN State Medical License 2010 - 2023
WI State Medical License 2015 - 2023
MA State Medical License 2009 - 2010- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 48 citationsA Single-Dose Pilot Trial of Intranasal Rapid-Acting Insulin in Apolipoprotein E4 Carriers with Mild–Moderate Alzheimer’s DiseaseMichael H. Rosenbloom, Terry R. Barclay, Maria Pyle, Brian Owens, Amanda Cagan
CNS Drugs. 2014-11-06 - 8 citationsRoutine cognitive screening in a neurology practice: Effect on physician behaviorMichael H. Rosenbloom, Soo Borson, Terry R. Barclay, Leah R. Hanson, Ann M. Werner
Neurology. Clinical Practice. 2016-02-01 - 2 citationsImplementation and review of the care ecosystem in an integrated healthcare system.Michael H Rosenbloom, Bhavani Kashyap, Ana Diaz-Ochoa, Jan Karrmann, Aleta Svitak
BMC Geriatrics. 2023-08-24
Press Mentions
UW Medicine Administers New Alzheimer’s Drug for the First TimeDecember 4th, 2023
External Links
- Leqembi Webinarhttps://depts.washington.edu/mbwc/news/article/leqembi-webinar
- What the FDA Approval of Lecanemab Means for Patients and Families: A Q&A with MBWC Clinicianshttps://depts.washington.edu/mbwc/news/article/lecanemab
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
